Select your language


Regulatory expert appointed to lead West Coast US client engagement for G&L

Posted on the 3rd June 2024

Richard Edmunds

Another exciting development for G&L.

G&L Healthcare Advisors is delighted to announce that Richard Edmunds, a 25-year veteran in regulatory affairs, will take on a new client engagement role and lead our US West coast business expansion, based out of G&L’s San Diego, California office.

Bringing decades of regulatory and clinical development experience, Richard will partner with both biotech and pharma customers to expedite drug development and product launch. Richard has a strong track record of helping over 50 companies secure regulatory approval.

Richard brings a unique and compelling combination of technical expertise and business acumen that helps our clients achieve their goals, whatever their stage of development.

He has assisted clients in initiating proof-of-concept studies and securing funding; reaching Ph1/2 clinical trial inflection point; gearing up for product approval and launch; increasing revenue through global expansion; or implementing cost-effective models for post-approval activities, technology solutions, and more.

Commenting on Richard’s appointment, G&L’s COO Dave Yungvirt said: “We are excited that Richard has agreed to help take G&L to the next level, as part of our continued growth, serving our West Coast clients to ultimately meet patient needs.”

Schedule your appointment with Richard today:

Ready to reach your potential?

Discover how G&L can help you do business better

Contact Us